Quanterix Corp QTRX Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Hrusovsky E Kevin

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,000

Price:

$76.36
Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Hrusovsky E Kevin

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-950

Price:

$75.08
Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Hrusovsky E Kevin

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,050

Price:

$73.76
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-7,900

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-8,199

Price:

$51.08
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,400

Price:

$50.38
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,333

Price:

$49.16
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-22,830

Price:

$47.87
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-7,200

Price:

$47.17
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

29,162

Price:

$8.16

Filings by filing date

Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Hrusovsky E Kevin

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,000

Price:

$76.36
Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Hrusovsky E Kevin

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-950

Price:

$75.08
Jan 19, 2021 (filed on Jan 21, 2021)

Insider Name:

Hrusovsky E Kevin

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,050

Price:

$73.76
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-7,900

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-8,199

Price:

$51.08
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,400

Price:

$50.38
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,333

Price:

$49.16
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-22,830

Price:

$47.87
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-7,200

Price:

$47.17
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Dekkers Marijn E

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

29,162

Price:

$8.16

News

Biz Brief

Sector: Healthcare	Industry: Advanced Medical Equipment & Technology

See Regulatory Filings on SEC

Company Contact

Address:	900 Middlesex Tpke BILLERICA MA 01821-3929
Tel:	N/A
Website:	https://www.quanterix.com
IR:	See website

Key People

E. Kevin Hrusovsky Chairman of the Board, President, Chief Executive Officer	Amol Chaubal Chief Financial Officer	William Geist Chief Operating Officer
David C. Duffy Senior Vice President, Research & Development and Chief Technology Officer	Dawn R. Mattoon Senior Vice President - Research Products	Mark T. Roskey Senior Vice President - Commercial and Accelerator
John J. Fry General Counsel, Secretary

Business Overview

Quanterix Corporation develops ultra-sensitive digital immunoassay platform and tools for life science research and diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers. The Company is also focusing to enable and develop novel therapies and diagnostics to facilitate in healthcare for earlier detection, monitoring, prognosis and, ultimately, prevention of disease. Simoa focuses on research and clinical testing applications and significantly advances enzyme-linked immunosorbent assay (ELISA) technology which is capable of unprecedented protein detection sensitivity. It also focuses on research and diagnostics for brain injuries, heart disease, cancer and other infectious diseases with its technology. The Company offers Simoa HD-1 analyzer, which is an automated immunoassay platform with multiplexing and custom assay capability.

Financial Overview

For the nine months ended 30 September 2020,Quanterix Corp revenues increased 48% to $60.2M. Net lossdecreased 27% to $21.7M. Revenues reflect Collaborationrevenue increase from $0K to $11.4M, Service Revenueincrease of 58% to $18.6M. Basic Earnings per Shareexcluding Extraordinary Items increased from -$1.25 to-$0.77.

Employees:	248 as of Dec 31, 2019

Reporting Currency:	U.S. Dollars
Enterprise value:	$2,377M as of Sep 30, 2020
Annual revenue (TTM):	$76.16M as of Sep 30, 2020
EBITDA (TTM):	-$29.13M as of Sep 30, 2020
Net annual income (TTM):	-$32.67M as of Sep 30, 2020
Free cash flow (TTM):	-$35.25M as of Sep 30, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	31,668,184 as of Oct 30, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Quanterix Corp (OQ:QTRX)